No disproportionate reporting of inflammatory arthritis following COVID-19 vaccination: a pharmacovigilance study using VAERS data

Rheumatoid Arthritis

Avoidable Hospitalizations in Persons with Rheumatoid Arthritis: A Population-Based Study Using Administrative Data

Arthritis Care Res (Hoboken)

Contreras DG, Barber CEH, Aviña-Zubieta JA, Quan H, Lee S, King JA, Barnabe C

doi: 10.1002/acr.25541

Further Publications Immunology

A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial

Lancet Haematol

Cook JA, Patten PEM, Peckham N, Moss P, Phillips N, Abhishek A, Roberts T, Hodges M, Talbot G, Barber V, Francis A, Shields AM, Duley L, Hoogeboom R, Willett BJ, Scott S, Parry-Jones N, Eyre TA, Plested G, Vandici G, Wandroo FA, Hutchinson C, Paneesha S, Murray DJ, Martinez-Calle N, Jenkins S, Heartin E, Parry HM

doi: 10.1016/S2352-3026(25)00008-0

Psoriatic Arthritis

Diagnostic delay and less intensive therapy for people with psoriatic arthritis compared with rheumatoid arthritis: a study nested within an English and Welsh audit data set

Ann Rheum Dis

Charlton RA, Gates E, Coates LC, Galloway J, McHugh N, McGrogan A, Hackett S, Brooke M, Cavill C, Tillett W

doi: 10.1016/j.ard.2025.02.020

Rheumatoid Arthritis

Agreement of administrative pharmacy dispensing with self-reported use of oral prednisone in US Veterans with rheumatoid arthritis

Arthritis Care Res (Hoboken)

Wallace BI, England BR, Baker JF, George MD, Sauer BC, Rojas J, Roul P, Wysham KD, Brubeck H, Smith I, Caplan L, Monach PA, Kerr GS, Kunkel G, Braaten T, Mikuls TR, Cannon GW

doi: 10.1002/acr.25580

Rheumatoid Arthritis

Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial

Ann Rheum Dis

Hawkins JA, Curtis JR, Weinberg A, Siegel SAR, Huffstutter JE, Loveless J, Gharib S, Reddy S, Sinha J, Ridley D, Messaoudi I, Park JK, Lee EB, Winthrop KL

doi: 10.1016/j.ard.2026.01.002

Rheumatoid Arthritis

Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs: data from an international collaboration of registries (the "JAK-pot" study)

Arthritis Rheumatol

Aymon R, Mongin D, Guemara R, Salis Z, Askling J, Choquette D, Codreanu C, Di Giuseppe D, Flouri I, Huschek D, Hyrich KL, Iannone F, Kvien TK, Leeb BF, Nordström D, Otero-Varela L, Pavelka K, Pombo-Suarez M, Rodrigues A, Rotar Z, Sidiropoulos P, Provan SA, Strangfeld A, Nina T, Zavada J, Kearsley-Fleet L, Courvoisier DS, Finckh A, Lauper K

doi: 10.1002/art.43188

Allergic Diseases

Real-Life Workup of Chronic Hand Eczema Using a Dedicated Case Report Form: A SIDAPA Multicentre Study

Contact Dermatitis

Gallo R, Guarneri F, Hansel K, Stingeni L, Napolitano M, Patruno C, Corazza M, Borghi A, Trave I, Martina E, Lauriola MM, Satta RR, Foti C, Romita P, Giuffrida R, Ferrucci SM, SIDAPA CHE Study Group

doi: 10.1111/cod.70105

OsteoarthritisRheumatoid Arthritis

The Patient-Reported Outcomes Measurement Information System scale v1.2 Global Health (PROMIS-GH) is useful to assess mental and physical health in individuals with chronic musculoskeletal pain, rheumatoid arthritis, hip/knee osteoarthritis, or people undergoing physiotherapy: Results of factor and item response theory analyses

Arthritis Care Res (Hoboken)

Giusti EM, Pellicciari L, Crins MHP, Dekker P, van der Esch M, van der Leeden M, Lems WF, Dekker J, Boers M, van Schaardenburg D, Joly J, Verschueren P, Van der Elst K, Westhovens R, Terwee CB, Roorda LD

doi: 10.1002/acr.25674

Psoriatic Arthritis

Antimicrobial use and serious infections among psoriatic arthritis patients after initiating tumor necrosis factor inhibitors: a nationwide matched cohort study

J Rheumatol

Thrastardottir T, Bjornsson AH, Ogdie A, Hauksdottir A, Kristinsson SY, Gudbjornsson B, Love TJ, ICEBIO

doi: 10.3899/jrheum.2025-0029

Related content

Avoidable Hospitalizations in Persons with Rheumatoid Arthritis: A Population-Based Study Using Administrative Data

A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial

Diagnostic delay and less intensive therapy for people with psoriatic arthritis compared with rheumatoid arthritis: a study nested within an English and Welsh audit data set

Agreement of administrative pharmacy dispensing with self-reported use of oral prednisone in US Veterans with rheumatoid arthritis

Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial

Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs: data from an international collaboration of registries (the "JAK-pot" study)

Real-Life Workup of Chronic Hand Eczema Using a Dedicated Case Report Form: A SIDAPA Multicentre Study

Antimicrobial use and serious infections among psoriatic arthritis patients after initiating tumor necrosis factor inhibitors: a nationwide matched cohort study